0001209191-19-026320.txt : 20190426
0001209191-19-026320.hdr.sgml : 20190426
20190426200650
ACCESSION NUMBER: 0001209191-19-026320
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190425
FILED AS OF DATE: 20190426
DATE AS OF CHANGE: 20190426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAVIOLETTE PAUL A
CENTRAL INDEX KEY: 0001191249
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 19773390
MAIL ADDRESS:
STREET 1: ONE BOSTON PLACE
STREET 2: 201 WASHINGTON STREET, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSENTERIX INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-25
0
0000876378
TRANSENTERIX INC.
TRXC
0001191249
LAVIOLETTE PAUL A
ONE BOSTON PLACE
201 WASHINGTON STREET, SUITE 3900
BOSTON
MA
02108
1
0
0
0
Common Stock
2019-04-25
4
A
0
20606
0.00
A
20606
D
Common Stock
2019-04-25
4
A
0
20380
0.00
A
40986
D
Stock Option Award
1.96
2019-04-25
4
A
0
29104
0.00
A
2029-04-25
Common Stock
29104
29104
D
Stock Option Award
1.96
2019-04-25
4
A
0
29428
0.00
A
2029-04-25
Common Stock
29428
29428
D
Represents restricted stock units. Each restricted stock unit represents the right to receive one share of the Registrant's common stock.
The restricted stock units remain subject to forfeiture until the first anniversary of the date of grant or, if earlier, the date of the next annual meeting of stockholders, as long as the reporting person remains in continuous service during the vesting period.
Amount of securities beneficially owned following reported transactions reflects the required assignment by the reporting person to an affiliated fund of the right to receive 40,950 shares of common stock upon vesting, on April 24, 2019, of RSUs granted to the reporting person on May 24, 2018.
The vesting schedule is 25% of the stock option award on July 1, 2019, October 1, 2019, January 1, 2020 and April 1, 2020. Subject to acceleration of vesting in full upon consummation of a change in control of the registrant.
The vesting schedule is 25% of the stock option award on July 1, 2019, October 1, 2019, January 1, 2020 and April 1, 2020. No acceleration of vesting for any unvested stock options upon the consummation of a change in control of the registrant.
/s/ Joshua Weingard attorney-in-fact for Paul A. LaViolette
2019-04-26